Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1213 of 6351
-
Blood test could help pick the right drug for tough colorectal cancers
Disease control OngoingThis phase II trial studies circulating cell-free tumor DNA testing to guide treatment with regorafenib or TAS-102 in patients with colorectal cancer that has spread to other areas of the body. Studying samples of blood from patients with colorectal cancer may help doctors unders…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Blood test may catch pelvic cancer relapse sooner
Diagnosis CompletedctDNA detection in patients with previously treated, HPV-induced, stage II or III invasive pelvic cancer and who are currently in post-treatment follow-up.
Sponsor: Institut Curie • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Can a tailored antibiotic regimen shorten endocarditis treatment without risk?
Disease control OngoingExisting guidelines recommend a duration of antibiotic treatment of endocarditis of 4-6 weeks one or more types of intravenously administered antibiotics. The long hospitalization increases several risks for the patient, including mental strain and increased loss of function. Fur…
Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Gene therapy trial targets HIV and lymphoma together
Disease control CompletedThe purpose of this study is to evaluate the safety and the feasibility, and the success of engraftment of the introduction of Cal-1 gene-transduced haematopoietic cell populations (Ttn and HSPCtn) in patients with HIV-1-related high-risk lymphoma.
Phase 1/2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Immune cells take on childhood cancer in early trial
Disease control OngoingThis NANT trial will determine the maximum tolerated dose (MTD) of autologous expanded natural killer (NK) cells when combined with standard dosing of dinutuximab and will assess the feasibility of adding lenalidomide at the recommended Phase II dose of the expanded NK cells with…
Phase 1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Calcium timing during bypass may cut need for heart drugs
Disease control CompletedTermination of cardiopulmonary bypass is a critical step in any cardiac surgical procedure and requires a thorough planning. Debate about rationale of calcium administration during weaning of cardiopulmonary bypass has been conducted for several decades; however, a consensus has …
Phase 4 • Sponsor: Meshalkin Research Institute of Pathology of Circulation • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Lifestyle overhaul may shield aging brains from memory loss
Prevention CompletedThe purpose of this research study is to see if lifestyle changes can protect memory and thinking (cognition) as we age. A recent study in Finland found that a combination of physical and cognitive exercise, diet, and social activity protected cognitive function in healthy older …
Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
New study aims to find best myeloma treatment for seniors
Disease control OngoingMultiple myeloma (MM) is a neoplastic disease deriving from an abnormal proliferation of monoclonal plasma cells in the bone marrow. The survival of MM patients varies from less than 6 months to more than 10 years depending on the stage of disease at diagnosis and prognostic fact…
Phase 4 • Sponsor: University of Turin, Italy • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Liver cancer combo therapy fails to outperform standard drug
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of lenvatinib (E7080/MK-7902) in combination with pembrolizumab (MK-3745) versus lenvatinib in combination with placebo as first-line therapy for the treatment of advanced hepatocellular carcinoma in adult participa…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cocktail of drugs shows promise for tough lung cancer
Disease control OngoingThis study is designed to determine the efficacy and safety of durvalumab and/or novel oncology therapies, with or without chemotherapy, for first-line Stage IV Non-Small Cell Lung Cancer (NSCLC)
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Tailored tumor attack: can custom drug cocktails beat recurrent glioblastoma?
Disease control CompletedThe current study will test the ability and likelihood of successfully implementing individualized combination treatment recommendations for adult patients with surgically-resectable recurrent glioblastoma in a timely fashion. Collected tumor tissue and blood will be examined usi…
Phase 1 • Sponsor: Jennifer Clarke • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could fewer radiation sessions mean fewer complications for sarcoma patients?
Disease control OngoingThis phase II trial studies the wound complication risk of shorter course, hypofractionated pre-surgery radiation therapy in treating patients with localized soft tissue sarcoma of the extremity of superficial trunk that can be removed by surgery. Hypofractionated radiation thera…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Heart scans may soon replace Needle-Based catheter tests
Diagnosis CompletedThe aim of this study is to evaluate the feasibility of collecting hemodynamic data from right catheterization, all anatomical, functional, flow and substrate determination data under MRI navigation.
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
New drug shows promise in preventing kidney transplant rejection
Disease control CompletedThis study was to compare CFZ533 to tacrolimus (TAC) in prevention of organ rejection in kidney transplant.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart surgery plus ablation: a One-Two punch against stubborn AFib?
Disease control Recruiting nowThe purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of non-paroxysmal atrial fibrillation (AF).
Sponsor: Medtronic Cardiac Surgery • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for kids with tough cancers: targeted drug attacks gene flaw
Disease control OngoingThis phase II Pediatric MATCH trial studies how well ulixertinib works in treating patients with solid tumors that have spread to other places in the body (advanced), non-Hodgkin lymphoma, or histiocytic disorders that have a genetic alteration (mutation) in a signaling pathway c…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope: immune drug may replace chemo for rare nasal lymphoma
Disease control OngoingThe purpose of this study is to test how well pembrolizumab shrinks Early-Stage NK/T-cell Lymphoma (ENKTL) in participants who have not yet received chemotherapy.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingEarly Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approach to identify affected infants, 2) address the impact on infants and families who screen positive, and 3) evaluate the …
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Could umbilical cord stem cells ease knee arthritis pain?
Disease control Recruiting nowThe purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Osteoarthritis, and in addition, provide basis for exploring the treatment regimen of UC-MSC therapy in different degree of cartilage defe…
Phase 2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Sound waves vs. prostate cancer: new study tracks Real-World results
Disease control Recruiting nowThe Sonablate HIFU device was approved by the U.S.FDA for prostate tissue ablation in October, 2015. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using HIFU through clinical data and health-related quality of life (…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC